Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Nikolai Constantin Brun"'
Autor:
Christian Fynbo Christiansen, Uffe Heide‐Jørgensen, Thomas Bøjer Rasmussen, Jacob Bodilsen, Ole Schmeltz Søgaard, Michael Maeng, Simon Tilma Vistisen, Morten Schmidt, Anton Pottegård, Lars Christian Lund, Mette Reilev, Jesper Hallas, Nanna Borup Johansen, Nikolai Constantin Brun, Henrik Toft Sørensen, Reimar Wernich Thomsen
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 19 (2020)
Background Angiotensin‐converting enzyme inhibitors (ACE‐Is) and angiotensin receptor blockers (ARBs) may worsen the prognosis of coronavirus disease 2019, but any association could be confounded by the cardiometabolic conditions indicating ACE
Externí odkaz:
https://doaj.org/article/ba09a66a2e4d409a85c66c0547e82b8b
Autor:
Lars Christian Lund, Kasper Bruun Kristensen, Mette Reilev, Steffen Christensen, Reimar Wernich Thomsen, Christian Fynbo Christiansen, Henrik Støvring, Nanna Borup Johansen, Nikolai Constantin Brun, Jesper Hallas, Anton Pottegård
Publikováno v:
PLoS Medicine, Vol 17, Iss 9, p e1003308 (2020)
BackgroundConcerns over the safety of non-steroidal anti-inflammatory drug (NSAID) use during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have been raised. We studied whether use of NSAIDs was associated with adverse outcom
Externí odkaz:
https://doaj.org/article/acc9fd793d9e4eefaa91ba9ebec563a5
Autor:
Anton Pottegård, Nanna B. Johansen, Martin Ernst, Jesper Hallas, Marianne Kragh Thomsen, Nikolai Constantin Brun, Mette Reilev, Henrik Støvring, Reimar W. Thomsen, Christian Fynbo Christiansen, Marianne Voldstedlund, Henrik Toft Sørensen, Anders Husby, Steffen Christensen, Lars Christian Lund, Jesper Kjaer, Kasper Bruun Kristensen
Publikováno v:
Clinical Epidemiology. 12:875-881
Background To facilitate research on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a prospective cohort of all Danish residents tested for SARS-CoV-2 in Denmark is established. Data structure All Danish residents tested by reverse tra
Publikováno v:
Clinical Pharmacology and Therapeutics
The increasing volume and complexity of data now being captured across multiple settings and devices offers the opportunity to deliver a better characterization of diseases, treatments, and the performance of medicinal products in individual healthca
Publikováno v:
Expert Opinion on Drug Safety. 19:533-535
Autor:
Claudia Riedel, Thomas Senderovitz, Aldana Rosso, Nikolai Constantin Brun, Karl Broich, Thomas Sudhop
Publikováno v:
The Lancet Oncology. 20:e336-e342
Master protocols combine several sub-trials, each with their own research objectives, which is usually presented as one single clinical trial application. Master protocols have become increasingly popular in oncology and haematology, as either basket
Publikováno v:
Ugeskrift for laeger. 183(10)
Efficacious and safe vaccines are important tools in handling the corona pandemic. As summarised in this review, the European approval system has undergone a tuning, streamlining and increase in efficiency in order to be able to quickly evaluate and
Autor:
Lars Christian Lund, Reimar W. Thomsen, Jesper Hallas, Stine Hasling Mogensen, Christian Fynbo Christiansen, Henrik Nielsen, Nikolai Constantin Brun, Anton Pottegård, Anders Koch
Publikováno v:
Lund, L C, Hallas, J, Nielsen, H, Koch, A, Mogensen, S H, Brun, N C, Christiansen, C F, Thomsen, R W & Pottegård, A 2021, ' Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission : a Danish population-based cohort study ', The Lancet Infectious Diseases, vol. 21, no. 10, pp. 1373-1382 . https://doi.org/10.1016/S1473-3099(21)00211-5
Lund, L C, Hallas, J, Nielsen, H, Koch, A, Mogensen, S H, Brun, N C, Christiansen, C F, Thomsen, R W & Pottegård, A 2021, ' Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission : a Danish population-based cohort study ', The Lancet. Infectious diseases, vol. 21, no. 10, pp. 1373-1382 . https://doi.org/10.1016/S1473-3099(21)00211-5
The Lancet. Infectious Diseases
Lund, L C, Hallas, J, Nielsen, H, Koch, A, Mogensen, S H, Brun, N C, Christiansen, C F, Thomsen, R W & Pottegård, A 2021, ' Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission : a Danish population-based cohort study ', The Lancet. Infectious diseases, vol. 21, no. 10, pp. 1373-1382 . https://doi.org/10.1016/S1473-3099(21)00211-5
The Lancet. Infectious Diseases
BACKGROUND: Individuals admitted to hospital for COVID-19 might have persisting symptoms (so-called long COVID) and delayed complications after discharge. However, little is known regarding the risk for those not admitted to hospital. We therefore ex
Autor:
Irmgard Eichler, Brigitte Schwarzer-Daum, Spiros Vamvakas, Anthony J. Humphreys, Nikolai Constantin Brun, Francesco Pignatti, Ana Hidalgo-Simon, Hans-Georg Eichler, Peter Arlett, Guido Rasi
Publikováno v:
Clinical Pharmacology and Therapeutics
Compared with drugs from the blockbuster era, recently authorized drugs and those expected in the future present a heterogenous mix of chemicals, biologicals, and cell and gene therapies, a sizable fraction being for rare diseases, and even individua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::157e53c0ac087c746cdfa83e032d30c8
http://hdl.handle.net/2108/294345
http://hdl.handle.net/2108/294345
Autor:
Anton Pottegård, Morten Schmidt, Jesper Hallas, Jacob Bodilsen, Henrik Toft Sørensen, Marianne Voldstedlund, Anders Husby, Mette Reilev, Lars Christian Lund, Reimar W. Thomsen, Nanna B. Johansen, Christian Fynbo Christiansen, Uffe Heide-Jørgensen, Nikolai Constantin Brun, Marianne Kragh Thomsen, Ole S. Søgaard, Simon T. Vistisen, Michael Maeng, Hans Erik Bøtker
Publikováno v:
Thorax
Christiansen, C F, Pottegård, A, Heide-Jørgensen, U, Bodilsen, J, Søgaard, O S, Maeng, M, Vistisen, S T, Schmidt, M, Lund, L C, Reilev, M, Hallas, J, Voldstedlund, M, Husby, A, Thomsen, M K, Johansen, N B, Brun, N C, Thomsen, R W, Bøtker, H E & Toft Sørensen, H 2021, ' SARS-CoV-2 infection and adverse outcomes in users of ACE inhibitors and angiotensin-receptor blockers : a nationwide case-control and cohort analysis ', Thorax, vol. 76, no. 4, pp. 370-379 . https://doi.org/10.1136/thoraxjnl-2020-215768
Christiansen, C F, Pottegård, A, Heide-Jørgensen, U, Bodilsen, J, Søgaard, O S, Maeng, M, Vistisen, S T, Schmidt, M, Lund, L C, Reilev, M, Hallas, J, Voldstedlund, M, Husby, A, Thomsen, M K, Johansen, N B, Brun, N C, Thomsen, R W, Bøtker, H E & Sørensen, H T 2021, ' SARS-CoV-2 infection and adverse outcomes in users of ACE inhibitors and angiotensin-receptor blockers : a nationwide case-control and cohort analysis ', Thorax, vol. 76, no. 4, 2020215768, pp. 370-379 . https://doi.org/10.1136/thoraxjnl-2020-215768
Christiansen, C F, Pottegård, A, Heide-Jørgensen, U, Bodilsen, J, Søgaard, O S, Maeng, M, Vistisen, S T, Schmidt, M, Lund, L C, Reilev, M, Hallas, J, Voldstedlund, M, Husby, A, Thomsen, M K, Johansen, N B, Brun, N C, Thomsen, R W, Bøtker, H E & Toft Sørensen, H 2021, ' SARS-CoV-2 infection and adverse outcomes in users of ACE inhibitors and angiotensin-receptor blockers : A nationwide case-control and cohort analysis ', Thorax, vol. 76, no. 4, pp. 370-379 . https://doi.org/10.1136/thoraxjnl-2020-215768
Christiansen, C F, Pottegård, A, Heide-Jørgensen, U, Bodilsen, J, Søgaard, O S, Maeng, M, Vistisen, S T, Schmidt, M, Lund, L C, Reilev, M, Hallas, J, Voldstedlund, M, Husby, A, Thomsen, M K, Johansen, N B, Brun, N C, Thomsen, R W, Bøtker, H E & Toft Sørensen, H 2021, ' SARS-CoV-2 infection and adverse outcomes in users of ACE inhibitors and angiotensin-receptor blockers : a nationwide case-control and cohort analysis ', Thorax, vol. 76, no. 4, pp. 370-379 . https://doi.org/10.1136/thoraxjnl-2020-215768
Christiansen, C F, Pottegård, A, Heide-Jørgensen, U, Bodilsen, J, Søgaard, O S, Maeng, M, Vistisen, S T, Schmidt, M, Lund, L C, Reilev, M, Hallas, J, Voldstedlund, M, Husby, A, Thomsen, M K, Johansen, N B, Brun, N C, Thomsen, R W, Bøtker, H E & Sørensen, H T 2021, ' SARS-CoV-2 infection and adverse outcomes in users of ACE inhibitors and angiotensin-receptor blockers : a nationwide case-control and cohort analysis ', Thorax, vol. 76, no. 4, 2020215768, pp. 370-379 . https://doi.org/10.1136/thoraxjnl-2020-215768
Christiansen, C F, Pottegård, A, Heide-Jørgensen, U, Bodilsen, J, Søgaard, O S, Maeng, M, Vistisen, S T, Schmidt, M, Lund, L C, Reilev, M, Hallas, J, Voldstedlund, M, Husby, A, Thomsen, M K, Johansen, N B, Brun, N C, Thomsen, R W, Bøtker, H E & Toft Sørensen, H 2021, ' SARS-CoV-2 infection and adverse outcomes in users of ACE inhibitors and angiotensin-receptor blockers : A nationwide case-control and cohort analysis ', Thorax, vol. 76, no. 4, pp. 370-379 . https://doi.org/10.1136/thoraxjnl-2020-215768
ObjectiveTo examine the impact of ACE inhibitor (ACE-I)/angiotensin receptor blocker (ARB) use on rate of SARS-CoV-2 infection and adverse outcomes.MethodsThis nationwide case-control and cohort study included all individuals in Denmark tested for SA